DTC Impact On African Americans To Be Examined In NMA, Industry, FDA Panel
Executive Summary
The National Medical Association plans to convene a panel of representatives from industry, FDA and patient groups to discuss direct-to-consumer advertising
You may also be interested in...
“Together Rx” Card Unites 7 Firms; Merck, Pharmacia, Wyeth Stay Apart
The "Together Rx" drug discount program could serve as the basis of a unified manufacturer/pharmacy program, McKesson Supply Solutions President Paul Julian told an April 10 press conference in New York City
Pfizer-Funded DTC Study Concludes Physicians Find Ads Beneficial
A Pfizer-funded study concludes that physicians find direct-to-consumer advertising of cholesterol and mood disorder drugs beneficial to the doctor-patient relationship
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011